Last reviewed · How we verify
Prevention of Recurrent Venous Thrombosis Associated with Malignancy
Approved treatments
- Heparin Sodium In Plastic Container · Merck & Co.
Heparin works by binding to Antithrombin-III, a protein that inhibits the formation of blood clots. - Heparin Sodium In Plastic Container · Fresenius Kabi
Heparin enhances Antithrombin III activity to inhibit coagulation factors Xa and IIa.
Clinical guidelines
- FDA label — 1L
Prevention of recurrent venous thrombosis associated with malignancy - FDA label — 1L
Prevention of recurrent venous thrombosis associated with malignancy - FDA label — 1L
Prevention of recurrent venous thrombosis associated with malignancy
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Prevention of Recurrent Venous Thrombosis Associated with Malignancy patent landscape — cliff calendar, originator estates, attackable patents
- Prevention of Recurrent Venous Thrombosis Associated with Malignancy treatment landscape brief
- Prevention of Recurrent Venous Thrombosis Associated with Malignancy treatment updates RSS
Frequently asked questions about Prevention of Recurrent Venous Thrombosis Associated with Malignancy
What drugs treat Prevention of Recurrent Venous Thrombosis Associated with Malignancy?
Tracked treatments include Heparin Sodium In Plastic Container.
What is the treatment for Prevention of Recurrent Venous Thrombosis Associated with Malignancy?
Standard treatment for Prevention of Recurrent Venous Thrombosis Associated with Malignancy includes Heparin Sodium In Plastic Container. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Prevention of Recurrent Venous Thrombosis Associated with Malignancy?
FDA label publishes guidelines for Prevention of Recurrent Venous Thrombosis Associated with Malignancy. 3 guideline references tracked.
Related
- Treatment landscape: Prevention of Recurrent Venous Thrombosis Associated with Malignancy patent cliff · Prevention of Recurrent Venous Thrombosis Associated with Malignancy CI report
- Treatment: Heparin Sodium In Plastic Container · Merck & Co.
- Treatment: Heparin Sodium In Plastic Container · Fresenius Kabi
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing